In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis.

Zi-Xuan Wu Yanhui Jiang Xuyan Huang Minjie Cai Kai Yuan Peidong HuangZuhong Wang

Published in: Evidence-based complementary and alternative medicine : eCAM (2022)

ETS1 may be a reliable biomarker for tumor prognosis and a viable prospective therapeutic target for human cancer immunotherapy (e.g., KIRP, MESO, BLCA, KIRC, and THYM).

Keyphrases

transcription factor
endothelial cells
induced pluripotent stem cells
pluripotent stem cells
binding protein
network analysis